Skip to main content
. Author manuscript; available in PMC: 2009 Aug 11.
Published in final edited form as: Cancer Res. 2008 Jun 1;68(11):4331–4339. doi: 10.1158/0008-5472.CAN-08-0943

Figure 5.

Figure 5

30d TCM exposed hMSCs become incorporated in the tumor stroma to a greater extent than the other co-injected cell types. Immunohistochemical staining for myofibroblast markers α-SMA, FSP and H&E stain in tumor stroma from naïve hMSC+MDAMB231 tumors (small tumor that did not grow in size); MDAMB231 plus matrigel tumors; MDAMB231 plus 5-aza treated hMSCs and tumors from MDAMB231 plus 30d TCM exposed hMSCs respectively.